Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

European reference network for rare vascular diseases (VASCERN) consensus statement for the screening and management of patients with pathogenic ACTA2 variants.

van de Laar IMBH, Arbustini E, Loeys B, Björck E, Murphy L, Groenink M, Kempers M, Timmermans J, Roos-Hesselink J, Benke K, Pepe G, Mulder B, Szabolcs Z, Teixidó-Turà G, Robert L, Emmanuel Y, Evangelista A, Pini A, von Kodolitsch Y, Jondeau G, De Backer J.

Orphanet J Rare Dis. 2019 Nov 21;14(1):264. doi: 10.1186/s13023-019-1186-2.

2.

Coronary artery assessment in Kawasaki disease with dual-source CT angiography to uncover vascular pathology.

van Stijn-Bringas Dimitriades D, Planken RN, Groenink M, Streekstra GJ, Kuijpers TW, Kuipers IM.

Eur Radiol. 2020 Jan;30(1):432-441. doi: 10.1007/s00330-019-06367-6. Epub 2019 Aug 19.

3.

Glycoproteomic Analysis of the Aortic Extracellular Matrix in Marfan Patients.

Yin 殷晓科 X, Wanga S, Fellows AL, Barallobre-Barreiro J, Lu R, Davaapil H, Franken R, Fava M, Baig F, Skroblin P, Xing Q, Koolbergen DR, Groenink M, Zwinderman AH, Balm R, de Vries CJM, Mulder BJM, Viner R, Jahangiri M, Reinhardt DP, Sinha S, de Waard V, Mayr M.

Arterioscler Thromb Vasc Biol. 2019 Sep;39(9):1859-1873. doi: 10.1161/ATVBAHA.118.312175. Epub 2019 Jul 18.

4.

Aortic root in competitive sports: eyes on the older athlete.

Jorstad HT, Groenink M.

Heart. 2019 Jun;105(12):900-901. doi: 10.1136/heartjnl-2019-314759. Epub 2019 Apr 10. No abstract available.

5.

The Potential Beneficial Effects of Resveratrol on Cardiovascular Complications in Marfan Syndrome Patients⁻Insights from Rodent-Based Animal Studies.

van Andel MM, Groenink M, Zwinderman AH, Mulder BJM, de Waard V.

Int J Mol Sci. 2019 Mar 5;20(5). pii: E1122. doi: 10.3390/ijms20051122. Review.

6.

Abnormal blood flow and wall shear stress are present in corrected aortic coarctation despite successful surgical repair.

Farag ES, van Ooij P, Boekholdt SM, Planken RN, Dukker KC, Bouma BJ, Groenink M, Koolbergen DR, Sojak V, Nederveen AJ, Hazekamp MG, de Mol BA, Kluin J.

J Cardiovasc Surg (Torino). 2019 Feb;60(1):152-154. doi: 10.23736/S0021-9509.18.10522-2. No abstract available.

PMID:
30648829
7.

Aortic dissection and prophylactic surgery in congenital heart disease.

Kuijpers JM, Koolbergen DR, Groenink M, Boekholdt SM, Meijboom FJ, Jongbloed MRM, Hoendermis ES, Duijnhouwer AL, Mulder BJM, Bouma BJ.

Int J Cardiol. 2019 Jan 1;274:113-116. doi: 10.1016/j.ijcard.2018.09.038. Epub 2018 Sep 12.

8.

Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disorders.

Overwater E, Marsili L, Baars MJH, Baas AF, van de Beek I, Dulfer E, van Hagen JM, Hilhorst-Hofstee Y, Kempers M, Krapels IP, Menke LA, Verhagen JMA, Yeung KK, Zwijnenburg PJG, Groenink M, van Rijn P, Weiss MM, Voorhoeve E, van Tintelen JP, Houweling AC, Maugeri A.

Hum Mutat. 2018 Sep;39(9):1173-1192. doi: 10.1002/humu.23565. Epub 2018 Jul 12.

9.

Aortic valve stenosis and aortic diameters determine the extent of increased wall shear stress in bicuspid aortic valve disease.

Farag ES, van Ooij P, Planken RN, Dukker KCP, de Heer F, Bouma BJ, Robbers-Visser D, Groenink M, Nederveen AJ, de Mol BAJM, Kluin J, Boekholdt SM.

J Magn Reson Imaging. 2018 Aug;48(2):522-530. doi: 10.1002/jmri.25956. Epub 2018 Feb 16.

10.

Effect of Losartan on Right Ventricular Dysfunction: Results From the Double-Blind, Randomized REDEFINE Trial (Right Ventricular Dysfunction in Tetralogy of Fallot: Inhibition of the Renin-Angiotensin-Aldosterone System) in Adults With Repaired Tetralogy of Fallot.

Bokma JP, Winter MM, van Dijk AP, Vliegen HW, van Melle JP, Meijboom FJ, Post MC, Berbee JK, Boekholdt SM, Groenink M, Zwinderman AH, Mulder BJM, Bouma BJ.

Circulation. 2018 Apr 3;137(14):1463-1471. doi: 10.1161/CIRCULATIONAHA.117.031438. Epub 2017 Dec 8.

PMID:
29222139
11.

Additional diagnostic value of CMR to the European Society of Cardiology (ESC) position statement criteria in a large clinical population of patients with suspected myocarditis.

Biesbroek PS, Hirsch A, Zweerink A, van de Ven PM, Beek AM, Groenink M, Windhausen F, Planken RN, van Rossum AC, Nijveldt R.

Eur Heart J Cardiovasc Imaging. 2018 Dec 1;19(12):1397-1407. doi: 10.1093/ehjci/jex308.

PMID:
29186442
12.

Surgical treatment of Marfan syndrome and related disorders is all about dealing with uncertainties.

Groenink M, Koolbergen DR.

Heart. 2018 Mar;104(6):454-455. doi: 10.1136/heartjnl-2017-312081. Epub 2017 Aug 16. No abstract available.

PMID:
28814491
13.

Aortic microcalcification is associated with elastin fragmentation in Marfan syndrome.

Wanga S, Hibender S, Ridwan Y, van Roomen C, Vos M, van der Made I, van Vliet N, Franken R, van Riel LA, Groenink M, Zwinderman AH, Mulder BJ, de Vries CJ, Essers J, de Waard V.

J Pathol. 2017 Nov;243(3):294-306. doi: 10.1002/path.4949. Epub 2017 Sep 21.

PMID:
28727149
14.

Clinical course of tricuspid regurgitation in repaired tetralogy of Fallot.

Woudstra OI, Bokma JP, Winter MM, Kiès P, Jongbloed MRM, Vliegen HW, Groenink M, Meijboom FJ, Mulder BJM, Bouma BJ.

Int J Cardiol. 2017 Sep 15;243:191-193. doi: 10.1016/j.ijcard.2017.05.122. Epub 2017 Jun 2.

PMID:
28601469
15.

Impact of Structural Cerebral Damage in Adults With Tetralogy of Fallot.

Sluman MA, Richard E, Bouma BJ, van Dalen JW, van Wanrooij LL, Groenink M, Caan MWA, Nederveen AJ, Mutsaerts HMM, Majoie CBLM, Schmand BA, Mulder BJM.

Circulation. 2017 May 9;135(19):1873-1875. doi: 10.1161/CIRCULATIONAHA.117.027865. No abstract available.

PMID:
28483835
16.

Value of Cardiovascular Magnetic Resonance Imaging in Noninvasive Risk Stratification in Tetralogy of Fallot.

Bokma JP, de Wilde KC, Vliegen HW, van Dijk AP, van Melle JP, Meijboom FJ, Zwinderman AH, Groenink M, Mulder BJM, Bouma BJ.

JAMA Cardiol. 2017 Jun 1;2(6):678-683. doi: 10.1001/jamacardio.2016.5818.

17.

Incidence, risk factors, and predictors of infective endocarditis in adult congenital heart disease: focus on the use of prosthetic material.

Kuijpers JM, Koolbergen DR, Groenink M, Peels KCH, Reichert CLA, Post MC, Bosker HA, Wajon EMCJ, Zwinderman AH, Mulder BJM, Bouma BJ.

Eur Heart J. 2017 Jul 7;38(26):2048-2056. doi: 10.1093/eurheartj/ehw591.

PMID:
28065906
18.

The effect of losartan therapy on ventricular function in Marfan patients with haploinsufficient or dominant negative FBN1 mutations.

den Hartog AW, Franken R, van den Berg MP, Zwinderman AH, Timmermans J, Scholte AJ, de Waard V, Spijkerboer AM, Pals G, Mulder BJ, Groenink M.

Neth Heart J. 2016 Nov;24(11):675-681.

19.

Transition from paediatric to adult care of adolescent patients with congenital heart disease: a pathway to optimal care.

Strijbosch AM, Zwart R, Blom NA, Bouma BJ, Groenink M, Boekholdt SM, de Winter R, Mulder BJ, Backx AP.

Neth Heart J. 2016 Nov;24(11):682-690.

20.

Mobile health in adults with congenital heart disease: current use and future needs.

Schuuring MJ, Backx AP, Zwart R, Veelenturf AH, Robbers-Visser D, Groenink M, Abu-Hanna A, Bruining N, Schijven MP, Mulder BJ, Bouma BJ.

Neth Heart J. 2016 Nov;24(11):647-652.

21.

Resveratrol Inhibits Aortic Root Dilatation in the Fbn1C1039G/+ Marfan Mouse Model.

Hibender S, Franken R, van Roomen C, Ter Braake A, van der Made I, Schermer EE, Gunst Q, van den Hoff MJ, Lutgens E, Pinto YM, Groenink M, Zwinderman AH, Mulder BJ, de Vries CJ, de Waard V.

Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1618-26. doi: 10.1161/ATVBAHA.116.307841. Epub 2016 Jun 9. Erratum in: Arterioscler Thromb Vasc Biol. 2016 Sep;36(9):e81.

22.

Pulmonary Valve Replacement After Repair of Pulmonary Stenosis Compared With Tetralogy of Fallot.

Bokma JP, Winter MM, Oosterhof T, Vliegen HW, van Dijk AP, Pieper PG, Meijboom FJ, Groenink M, Mulder BJM, Bouma BJ.

J Am Coll Cardiol. 2016 Mar 8;67(9):1123-1124. doi: 10.1016/j.jacc.2015.12.032. No abstract available.

23.

Genotype impacts survival in Marfan syndrome.

Franken R, Groenink M, de Waard V, Feenstra HM, Scholte AJ, van den Berg MP, Pals G, Zwinderman AH, Timmermans J, Mulder BJ.

Eur Heart J. 2016 Nov 14;37(43):3285-3290. Epub 2016 Jan 18.

PMID:
26787436
24.

Coronary artery calcification score as tool for risk assessment among families with premature coronary artery disease.

Mulders TA, Taraboanta C, Franken LC, van Heel E, Klass G, Forster BB, Arad Y, Boekholdt SM, Groenink M, Fröhlich J, Guerci AD, Stroes ES, Pinto-Sietsma SJ.

Atherosclerosis. 2016 Feb;245:155-60. doi: 10.1016/j.atherosclerosis.2015.12.008. Epub 2015 Dec 11.

PMID:
26724526
25.

How to treat Marfan syndrome: an update.

Groenink M, Mulder BJ.

Eur Heart J. 2016 Mar 21;37(12):986-7. doi: 10.1093/eurheartj/ehv589. Epub 2015 Nov 7. No abstract available.

PMID:
26547225
26.

Preoperative thresholds for mid-to-late haemodynamic and clinical outcomes after pulmonary valve replacement in tetralogy of Fallot.

Bokma JP, Winter MM, Oosterhof T, Vliegen HW, van Dijk AP, Hazekamp MG, Koolbergen DR, Groenink M, Mulder BJ, Bouma BJ.

Eur Heart J. 2016 Mar 7;37(10):829-35. doi: 10.1093/eurheartj/ehv550. Epub 2015 Oct 27.

PMID:
26508165
27.

Cardiovascular imaging in children and adults following Kawasaki disease.

Dietz SM, Tacke CE, Kuipers IM, Wiegman A, de Winter RJ, Burns JC, Gordon JB, Groenink M, Kuijpers TW.

Insights Imaging. 2015 Dec;6(6):697-705. doi: 10.1007/s13244-015-0422-0. Epub 2015 Jul 27.

28.

Individualised prediction of pulmonary homograft durability in tetralogy of Fallot.

Bokma JP, Winter MM, Oosterhof T, Vliegen HW, van Dijk AP, Hazekamp MG, Koolbergen DR, Groenink M, Mulder BJ, Bouma BJ.

Heart. 2015 Nov;101(21):1717-23. doi: 10.1136/heartjnl-2015-307754. Epub 2015 Jul 14.

PMID:
26175476
29.

Platypnoea-orthodeoxia syndrome, an underdiagnosed cause of hypoxaemia: four cases and the possible underlying mechanisms.

Nassif M, Lu H, Konings TC, Bouma BJ, Vonk Noordegraaf A, Straver B, Blom NA, Clur SA, Backx AP, Groenink M, Boekholdt SM, Koolbergen DR, Hazekamp MG, Mulder BJ, de Winter RJ.

Neth Heart J. 2015 Nov;23(11):539-45. doi: 10.1007/s12471-015-0714-5.

30.

Increased aortic tortuosity indicates a more severe aortic phenotype in adults with Marfan syndrome.

Franken R, El Morabit A, de Waard V, Timmermans J, Scholte AJ, van den Berg MP, Marquering H, Planken NR, Zwinderman AH, Mulder BJ, Groenink M.

Int J Cardiol. 2015 Sep 1;194:7-12. doi: 10.1016/j.ijcard.2015.05.072. Epub 2015 May 15.

PMID:
26005802
31.

Design and rationale of a prospective, collaborative meta-analysis of all randomized controlled trials of angiotensin receptor antagonists in Marfan syndrome, based on individual patient data: A report from the Marfan Treatment Trialists' Collaboration.

Pitcher A, Emberson J, Lacro RV, Sleeper LA, Stylianou M, Mahony L, Pearson GD, Groenink M, Mulder BJ, Zwinderman AH, De Backer J, De Paepe AM, Arbustini E, Erdem G, Jin XY, Flather MD, Mullen MJ, Child AH, Forteza A, Evangelista A, Chiu HH, Wu MH, Sandor G, Bhatt AB, Creager MA, Devereux RB, Loeys B, Forfar JC, Neubauer S, Watkins H, Boileau C, Jondeau G, Dietz HC, Baigent C.

Am Heart J. 2015 May;169(5):605-12. doi: 10.1016/j.ahj.2015.01.011. Epub 2015 Feb 12.

32.

Severe tricuspid regurgitation is predictive for adverse events in tetralogy of Fallot.

Bokma JP, Winter MM, Oosterhof T, Vliegen HW, van Dijk AP, Hazekamp MG, Koolbergen DR, Groenink M, Mulder BJ, Bouma BJ.

Heart. 2015 May 15;101(10):794-9. doi: 10.1136/heartjnl-2014-306919. Epub 2015 Mar 31.

PMID:
25828460
33.

The risk for type B aortic dissection in Marfan syndrome.

den Hartog AW, Franken R, Zwinderman AH, Timmermans J, Scholte AJ, van den Berg MP, de Waard V, Pals G, Mulder BJ, Groenink M.

J Am Coll Cardiol. 2015 Jan 27;65(3):246-54. doi: 10.1016/j.jacc.2014.10.050.

34.

Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome.

Franken R, den Hartog AW, Radonic T, Micha D, Maugeri A, van Dijk FS, Meijers-Heijboer HE, Timmermans J, Scholte AJ, van den Berg MP, Groenink M, Mulder BJ, Zwinderman AH, de Waard V, Pals G.

Circ Cardiovasc Genet. 2015 Apr;8(2):383-8. doi: 10.1161/CIRCGENETICS.114.000950. Epub 2015 Jan 22.

PMID:
25613431
35.

The revised role of TGF-β in aortic aneurysms in Marfan syndrome.

Franken R, Radonic T, den Hartog AW, Groenink M, Pals G, van Eijk M, Lutter R, Mulder BJ, Zwinderman AH, de Waard V; COMPARE study group.

Neth Heart J. 2015 Feb;23(2):116-21. doi: 10.1007/s12471-014-0622-0.

36.

Computed tomography coronary angiography should be performed in all patients with Marfan Syndrome prior to aortic root replacement.

Winter MM, Koolbergen DR, Groenink M, Franken R, Mulder BJ, Bouma BJ.

Int J Cardiol. 2014 Dec 15;177(2):e70-1. doi: 10.1016/j.ijcard.2014.09.152. Epub 2014 Oct 5. No abstract available.

PMID:
25304071
37.

No beneficial effect of general and specific anti-inflammatory therapies on aortic dilatation in Marfan mice.

Franken R, Hibender S, den Hartog AW, Radonic T, de Vries CJ, Zwinderman AH, Groenink M, Mulder BJ, de Waard V.

PLoS One. 2014 Sep 19;9(9):e107221. doi: 10.1371/journal.pone.0107221. eCollection 2014.

38.

Increased carotid intima-media thickness predicts cardiovascular events in aortic coarctation.

Luijendijk P, Lu H, Heynneman FB, Huijgen R, de Groot EE, Vriend JW, Vliegen HW, Groenink M, Bouma BJ, Mulder BJ.

Int J Cardiol. 2014 Oct 20;176(3):776-81. doi: 10.1016/j.ijcard.2014.07.090. Epub 2014 Aug 17.

PMID:
25205481
39.

Beneficial effect of high dose statins on the vascular wall in patients with repaired aortic coarctation?

Luijendijk P, Bouma BJ, Vriend JW, Groenink M, Vliegen HW, de Groot E, Pieper PG, van Dijk AP, Sieswerda GT, Konings TC, Stroes ES, Zwinderman AH, Mulder BJ.

Int J Cardiol. 2014 Sep;176(1):40-7. doi: 10.1016/j.ijcard.2014.06.016. Epub 2014 Jun 28.

PMID:
25042661
40.

Evaluating the systemic right ventricle by cardiovascular magnetic resonance: short axis or axial slices?

van der Bom T, Romeih S, Groenink M, Pieper PG, van Dijk AP, Helbing WA, Zwinderman AH, Mulder BJ, Bouma BJ.

Congenit Heart Dis. 2015 Jan-Feb;10(1):69-77. doi: 10.1111/chd.12182. Epub 2014 Apr 21.

PMID:
24751199
41.

Unroofed coronary sinus newly diagnosed in adult patients after corrected congenital heart disease.

Pérez Matos AJ, Planken RN, Bouma BJ, Groenink M, Backx AP, de Winter RJ, Koolbergen DR, Mulder BJ, Boekholdt SM.

Neth Heart J. 2014 May;22(5):240-5. doi: 10.1007/s12471-014-0533-0.

42.

5-year serial follow-up of clinical condition and ventricular function in patients after repair of tetralogy of Fallot.

Luijnenburg SE, Helbing WA, Moelker A, Kroft LJ, Groenink M, Roos-Hesselink JW, de Rijke YB, Hazekamp MG, Bogers AJ, Vliegen HW, Mulder BJ.

Int J Cardiol. 2013 Nov 30;169(6):439-44. doi: 10.1016/j.ijcard.2013.10.013. Epub 2013 Oct 11.

PMID:
24182670
43.

Contemporary predictors of death and sustained ventricular tachycardia in patients with repaired tetralogy of Fallot enrolled in the INDICATOR cohort.

Valente AM, Gauvreau K, Assenza GE, Babu-Narayan SV, Schreier J, Gatzoulis MA, Groenink M, Inuzuka R, Kilner PJ, Koyak Z, Landzberg MJ, Mulder B, Powell AJ, Wald R, Geva T.

Heart. 2014 Feb;100(3):247-53. doi: 10.1136/heartjnl-2013-304958. Epub 2013 Oct 31.

44.

Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial.

Groenink M, den Hartog AW, Franken R, Radonic T, de Waard V, Timmermans J, Scholte AJ, van den Berg MP, Spijkerboer AM, Marquering HA, Zwinderman AH, Mulder BJ.

Eur Heart J. 2013 Dec;34(45):3491-500. doi: 10.1093/eurheartj/eht334. Epub 2013 Sep 2.

PMID:
23999449
45.

Clinical features differ substantially between Caucasian and Asian populations of Marfan syndrome.

Franken R, den Hartog AW, van de Riet L, Timmermans J, Scholte AJ, van den Berg MP, de Waard V, Zwinderman AH, Groenink M, Yip JW, Mulder BJ.

Circ J. 2013;77(11):2793-8. Epub 2013 Aug 29.

46.

Left ventricular fibrosis in adults after coarctation repair, does it play a role?

Luijendijk P, Bouma BJ, Vriend JW, Groenink M, Spijkerboer AM, Mulder BJ.

Int J Cardiol. 2013 Oct 12;168(5):5029-30. doi: 10.1016/j.ijcard.2013.07.158. Epub 2013 Jul 26. No abstract available.

PMID:
23938218
47.

Right ventricular end-diastolic volume combined with peak systolic blood pressure during exercise identifies patients at risk for complications in adults with a systemic right ventricle.

van der Bom T, Winter MM, Groenink M, Vliegen HW, Pieper PG, van Dijk AP, Sieswerda GT, Roos-Hesselink JW, Zwinderman AH, Mulder BJ, Bouma BJ.

J Am Coll Cardiol. 2013 Sep 3;62(10):926-36. doi: 10.1016/j.jacc.2013.06.026. Epub 2013 Jul 10.

48.

Aortic disease in patients with Marfan syndrome: aortic volume assessment for surveillance.

den Hartog AW, Franken R, de Witte P, Radonic T, Marquering HA, van der Steen WE, Timmermans J, Scholte AJ, van den Berg MP, Zwinderman AH, Mulder BJ, Groenink M.

Radiology. 2013 Nov;269(2):370-7. doi: 10.1148/radiol.13122310. Epub 2013 Jun 25.

PMID:
23801775
49.

Circulating transforming growth factor-β as a prognostic biomarker in Marfan syndrome.

Franken R, den Hartog AW, de Waard V, Engele L, Radonic T, Lutter R, Timmermans J, Scholte AJ, van den Berg MP, Zwinderman AH, Groenink M, Mulder BJ.

Int J Cardiol. 2013 Oct 3;168(3):2441-6. doi: 10.1016/j.ijcard.2013.03.033. Epub 2013 Apr 10.

PMID:
23582687
50.

Surgical versus percutaneous treatment of aortic coarctation: new standards in an era of transcatheter repair.

Luijendijk P, Bouma BJ, Groenink M, Boekholdt M, Hazekamp MG, Blom NA, Koolbergen DR, de Winter RJ, Mulder BJ.

Expert Rev Cardiovasc Ther. 2012 Dec;10(12):1517-31. doi: 10.1586/erc.12.158. Review.

PMID:
23253276

Supplemental Content

Loading ...
Support Center